Platform 02 · Biotech

Five steps become one

Purification is 50% to 80% of the production cost of a therapeutic protein. Not the fermentation, not the raw material: the purification. The Aybar Protocol collapses that sequence into a single chromatography step, on the equipment producers already own.

Validated on enzymes Runs on existing FPLC / HPLC Industrial pilot sought
CRUDE EXTRACT ION EXCHANGE, ONE PASS PURIFIED 23× IN ONE STEP

The comparison

Against hydroxylapatite chromatography, on the same enzyme

The reference figures below come from the purification of HGPRT’ase, the enzyme the protocol was developed and tested on. It has since been applied to several others, and is applicable in principle to any polypeptide or protein complex with ionic functional groups.

1 stepReplaces a five-step sequence
23×Degree of purification in that single step, against 5×
4–6 daysTo process 60 lb of yeast, against 6 months
80+Affinity column reuse cycles, against 3
CONVENTIONAL · 5 STEPS · 6 MONTHS 010203 0405 AYBAR PROTOCOL · 1 STEP · 4–6 DAYS SINGLE PASS
Step count and elapsed time, same starting material
Purification of the enzyme HGPRT’ase
FeatureAybar ProtocolHydroxylapatite
Stages1 step5 steps
Purification in this step23 fold5 fold
Time for 60 lb of yeast4–6 days6 months
Dilution in the effluent3–5 fold50 fold
Elution buffer volume1–3× void volume30× void volume
Column regeneration3 hours / 250 mlSeveral days / 250 ml
Affinity column lifetimeMultiple cycles3 cycles

Why it compounds

The saving is not in one line item

Older methods carry a specific set of drawbacks: heavy buffer consumption, low flow rates, loss of protein activity during the process, heavy dilution of the extract, difficult or impossible column regeneration, and a low purification fold that leaves debris polypeptides behind.

That last one is the expensive one, and it is the one nobody budgets for. Debris carried into the affinity chromatography step shortens the life of the affinity column, which is the most expensive consumable in the sequence. Purifying harder early makes the costly step last longer.

No capital expenditure

Adoption requires a fast protein liquid chromatography instrument, or any system with programmable injection, programmable buffer gradient, a pumping system, and preparatory columns packed with a suitable ion exchange resin. If a producer is purifying protein today, they already have this. No new machinery, no new facility, no capital line item.

ELUTION BUFFER · COLUMN VOID VOLUMES 30× 1–3× AFFINITY COLUMN LIFETIME · CYCLES 3 CYCLES 80+ CYCLES BUFFER CONSUMPTION 80–90% reduction vs. standard industrial process
Consumable economics, the part that repeats every batch

Applications

Where purification cost decides the business case

Functional food ingredients

Collagen, soy and pea protein streams where yield and clean-label processing determine margin.

Nutraceutical extraction

Enzymes and immune peptides that are currently uneconomic to purify at scale.

Biotech and therapeutic proteins

Interferons, immunoglobulins and monoclonal antibodies, where purification dominates cost of goods outright.

Plant-based and alternative proteins

Emerging protein sources whose commercial viability depends on extraction economics rather than on raw material supply.

GLOBAL MARKET SIZE · 2025 FUNCTIONAL FOODS$280B THERAPEUTIC PROTEINS$227B NUTRACEUTICALS$150B PLANT-BASED$40B PURIFICATION$19B TOTAL ADDRESSABLE >$700B 1% = $7B
Segments where the protocol applies

Commercial model

Paid out of the savings

Licensing priced on production volume, purification-as-a-service for producers who would rather not run it in house, and joint ventures with ingredient firms. Aybar Ecotechnologies retains a shareholding in the commercialization entity.

→

An offer that makes the claim testable. We will implement the procedure on one of your protein products at no cost to you, provided you supply the starting material and the facility. If the numbers on this page do not reproduce on your material, you have lost nothing.

Licensing & partnerships

Work with us on what comes next

Aybar Ecotechnologies works through licensing, joint ventures, and equity structures. Request the investor brief for a specific platform, or schedule a technical demonstration with our research team.